[go: up one dir, main page]

DE69635304D1 - Faenger fuer oxidantien - Google Patents

Faenger fuer oxidantien

Info

Publication number
DE69635304D1
DE69635304D1 DE69635304T DE69635304T DE69635304D1 DE 69635304 D1 DE69635304 D1 DE 69635304D1 DE 69635304 T DE69635304 T DE 69635304T DE 69635304 T DE69635304 T DE 69635304T DE 69635304 D1 DE69635304 D1 DE 69635304D1
Authority
DE
Germany
Prior art keywords
oxidants
faenger
relates
modulating
processes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69635304T
Other languages
English (en)
Other versions
DE69635304T2 (de
Inventor
P Trova
D Crapo
Irwin Fridovich
Tim Oury
J Day
J Folz
A Freeman
Ines Batinic-Haberle
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Durham
UAB Research Foundation
Aeolus Sciences Inc
Duke University
Original Assignee
University of Durham
UAB Research Foundation
Aeolus Sciences Inc
Duke University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/476,866 external-priority patent/US5994339A/en
Application filed by University of Durham, UAB Research Foundation, Aeolus Sciences Inc, Duke University filed Critical University of Durham
Publication of DE69635304D1 publication Critical patent/DE69635304D1/de
Application granted granted Critical
Publication of DE69635304T2 publication Critical patent/DE69635304T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/22Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains four or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/545Heterocyclic compounds
    • A61K47/546Porphyrines; Porphyrine with an expanded ring system, e.g. texaphyrine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • A61P39/06Free radical scavengers or antioxidants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B82NANOTECHNOLOGY
    • B82YSPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004Oxidoreductases (1.)
    • C12N9/0089Oxidoreductases (1.) acting on superoxide as acceptor (1.15)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Nanotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
DE69635304T 1995-06-07 1996-06-07 Faenger fuer oxidantien Expired - Lifetime DE69635304T2 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US476866 1995-06-07
US08/476,866 US5994339A (en) 1993-10-15 1995-06-07 Oxidant scavengers
US61341896A 1996-03-11 1996-03-11
US613418 1996-03-11
PCT/US1996/010497 WO1996040223A1 (en) 1995-06-07 1996-06-07 Oxidant scavengers

Publications (2)

Publication Number Publication Date
DE69635304D1 true DE69635304D1 (de) 2006-03-02
DE69635304T2 DE69635304T2 (de) 2006-07-20

Family

ID=27045322

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69635304T Expired - Lifetime DE69635304T2 (de) 1995-06-07 1996-06-07 Faenger fuer oxidantien

Country Status (9)

Country Link
EP (1) EP0831891B1 (de)
JP (1) JPH11509180A (de)
AT (1) ATE306936T1 (de)
AU (1) AU725602B2 (de)
CA (1) CA2223407C (de)
DE (1) DE69635304T2 (de)
ES (1) ES2249784T3 (de)
IL (1) IL122451A0 (de)
WO (1) WO1996040223A1 (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6127356A (en) 1993-10-15 2000-10-03 Duke University Oxidant scavengers
US5834457A (en) * 1996-01-26 1998-11-10 The Regents Of The University Of California Method of modulating radical formation by mutant cuznsod enzymes
AU737650B2 (en) 1997-11-03 2001-08-23 Duke University Substituted porphyrins
DE69928655T2 (de) 1998-04-24 2006-08-24 Duke University Substituierte porphyrine
WO2000009111A2 (en) * 1998-08-11 2000-02-24 The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services Inhibitors of amyloid formation
WO2000012512A1 (en) 1998-08-28 2000-03-09 Destiny Pharma Limited Porphyrin derivatives, their use in photodynamic therapy and medical devices containing them
DK1155019T3 (da) * 1999-01-25 2006-04-18 Nat Jewish Med & Res Center Substituerede porphyriner og deres terapeutiske anvendelse
US6403788B1 (en) 2000-07-11 2002-06-11 Eukarion, Inc. Non-genotoxic metalloporphyrins as synthetic catalytic scavengers of reactive oxygen species
EP1439842A4 (de) 2001-06-01 2009-09-02 Nat Jewish Med & Res Center Oxidantienfänger zur behandlung von diabetes oder zur verwendung bei der transplantation oder induktion von immuntoleranz
EP1513537A4 (de) 2002-06-07 2006-09-06 Univ Duke Substituierte porphyrine
ITFI20020200A1 (it) * 2002-10-21 2004-04-22 Molteni & C Dei Flii Alitti S P A Societa L Porfirine meso-sostituite.
EP1692187B1 (de) * 2003-10-31 2012-06-27 Tae-Yoon Kim EC SOD und zelltransduzierende EC SOD und Verwendung davon
US8318803B2 (en) 2003-10-31 2012-11-27 Tae-Yoon Kim EC SOD and use thereof
MXPA06011244A (es) * 2004-03-29 2007-04-13 Inotek Pharmaceuticals Corp Compuestos de porfirina sustituida por piridilo, y metodos de uso de los mismos.
JP2009510083A (ja) 2005-09-28 2009-03-12 イノテック ファーマシューティカルズ コーポレイション N−ベンジル置換ピリジルポルフィリン化合物およびその使用方法
WO2008114017A2 (en) * 2007-03-19 2008-09-25 Imperial Innovations Limited Compositions and methods relating to influenza infection
KR20140001257A (ko) 2008-05-13 2014-01-06 유니버시티 오브 캔사스 금속 추출 펩타이드(map) 태그 및 관련된 방법
US11382895B2 (en) 2008-05-23 2022-07-12 National Jewish Health Methods for treating injury associated with exposure to an alkylating species
JP6182775B2 (ja) * 2011-09-21 2017-08-23 国立大学法人 岡山大学 金属ポルフィリン錯体、その製造方法及びそれからなる二酸化炭素固定化触媒、並びに、環状炭酸エステルの製造方法
CN102584836B (zh) * 2011-12-31 2014-04-16 中国科学院化学研究所 一种卟啉笼状化合物及其制备方法与应用
US9187735B2 (en) 2012-06-01 2015-11-17 University Of Kansas Metal abstraction peptide with superoxide dismutase activity
US8883857B2 (en) 2012-12-07 2014-11-11 Baylor College Of Medicine Small molecule xanthine oxidase inhibitors and methods of use
JP6444211B2 (ja) * 2015-02-24 2018-12-26 学校法人同志社 ポルフィリン誘導体、及びこれを含む光増感剤等
CN105399750B (zh) * 2015-12-11 2018-07-17 西北师范大学 四氮唑卟啉金属配合物及其合成和作为染料敏化剂的应用
CN112694887B (zh) * 2020-12-07 2024-04-26 黑龙江省农业科学院植物保护研究所 一种发光型传感器及其构筑方法与在检测植物水杨酸含量中的应用

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3464252D1 (en) * 1983-06-03 1987-07-23 Hoffmann La Roche Labelled molecules for fluorescence immunoassays and processes and intermediates for their preparation
GB8429845D0 (en) * 1984-11-26 1985-01-03 Efamol Ltd Porphyrins & cancer treatment
US5248603A (en) * 1985-09-03 1993-09-28 Symbicom Aktiebolag Superoxide dismutase
US4746735A (en) * 1986-11-21 1988-05-24 The Dow Chemical Company Regiospecific aryl nitration of meso-substituted tetraarylporphyrins
US4892941A (en) * 1987-04-17 1990-01-09 Dolphin David H Porphyrins
US5051337A (en) * 1987-06-10 1991-09-24 Director-General Of Agency Of Industrial Science And Technology Optical recording material
GB8805849D0 (en) * 1988-03-11 1988-04-13 Efamol Holdings Porphyrins & cancer treatment
DE3809671A1 (de) * 1988-03-18 1989-09-28 Schering Ag Porphyrin-komplexverbindungen, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische mittel
FR2632187B1 (fr) * 1988-06-02 1990-09-14 Centre Nat Rech Scient Derives de metalloporphyrines, leur preparation, leur application en therapeutique et leur utilisation pour la preparation de molecules hybrides
US5171680A (en) * 1988-06-14 1992-12-15 Chiron Corporation Superoxide dismutase analogs having novel binding properties
DK455789D0 (da) * 1989-09-15 1989-09-15 Symbicom Ab Polypeptid
US5236915A (en) * 1990-05-31 1993-08-17 Health Research, Inc. Meso poly(4-sulfonatophenyl) porphines as MRI image enhancing agents
FR2676738B1 (fr) * 1991-05-22 1995-05-05 Ir2M Nouveau derive organique de metal de transition a structure porphyrinique, composition therapeutique le contenant, en particulier a activite hypoglycemiante.
US5262532A (en) * 1991-07-22 1993-11-16 E.R. Squibb & Sons, Inc. Paramagnetic metalloporphyrins as contrast agents for magnetic resonance imaging
US5747026A (en) * 1993-10-15 1998-05-05 University Of Alabama At Birmingham Research Foundation Antioxidants

Also Published As

Publication number Publication date
EP0831891B1 (de) 2005-10-19
AU725602B2 (en) 2000-10-12
WO1996040223A1 (en) 1996-12-19
EP0831891A4 (de) 1999-02-03
JPH11509180A (ja) 1999-08-17
CA2223407C (en) 2011-02-08
IL122451A0 (en) 1998-06-15
EP0831891A1 (de) 1998-04-01
AU6387096A (en) 1996-12-30
CA2223407A1 (en) 1996-12-19
ATE306936T1 (de) 2005-11-15
DE69635304T2 (de) 2006-07-20
ES2249784T3 (es) 2006-04-01

Similar Documents

Publication Publication Date Title
DE69635304D1 (de) Faenger fuer oxidantien
DE69434313D1 (de) Superoxiddismutase memetika
ATE238307T1 (de) Substituierte porphyrinen
DE69928655D1 (de) Substituierte porphyrine
MXPA01007451A (es) Porfirinas sustituidas.
NO2015027I1 (no) Mepolizumab
MY129189A (en) Prostaglandin agonists and their use to treat bone disorders
BG104247A (en) Resorcinol derivatives
GB9514451D0 (en) Sustained-release formulation
BG104780A (en) Inhibitors of phospholipase enzymes
AU5624699A (en) Use of 5ht-6 antagonists
MX9700557A (es) Dihidrobenzofuranos.
PT865294E (pt) Processo para a reducao ou a manutencao de niveis reduzidos de lipidos no sangue utilizando composicoes de proteina ob
ATE510552T1 (de) Verfahren zur herstellung von sekretierte verkurzte varianten des humanen thyrotropinrezeptors
HK1028568A1 (en) Alpha-ketoamide multicatalytic protease inhibitors
ID22718A (id) Senyawa-senyawa tetrahidropirido
ATE305517T1 (de) Neurotrypsin
BG104292A (en) Methods and compositions for the treatment of rheumatoid arthritis
ATE215084T1 (de) Imidazopyridin-azolidinone
DE59506532D1 (de) Lutschbonbon mit zahnbelags-neutralisierender wirkung
ZA949564B (en) Method for treating constipation using dimeticone.
ZA983231B (en) Substituted benzyloxyimino compounds.
DE69924385D1 (de) Verwendung von angiotensin zur behandlung von krebsmetastasierung
ES2122912A1 (es) Inhibidores de metalocarboxipeptidasas y moleculas derivadas como agentes antitumorales.
PE61999A1 (es) Compuestos de tetrahidropiridina

Legal Events

Date Code Title Description
8364 No opposition during term of opposition